SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr | ₹9.37 Cr |
What is the latest Total Non-Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹1.01 Cr |
| Mar2021 | ₹9.37 Cr |
How is Total Non-Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 20.42 | |
| Mar2024 | ₹11 Cr | 33.16 | |
| Mar2023 | ₹8.14 Cr | 709.34 | |
| Mar2022 | ₹1.01 Cr | -89.26 | |
| Mar2021 | ₹9.37 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses